121 related articles for article (PubMed ID: 38155009)
1. EXT2: a novel prognostic and predictive biomarker for head and neck squamous cell carcinoma.
Selvan AJA; Kannan B; Pandi C; Jayaseelan VP; Arumugam P
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):282-289. PubMed ID: 38155009
[TBL] [Abstract][Full Text] [Related]
2. Exostoisns (EXT1/2) in Head and Neck Cancers: An In Silico Analysis and Clinical Correlates.
Wang Y; Huang Y; Zhu H; Guo Z; Cheng J; Zhang C; Zhong M
Int Dent J; 2024 Jun; 74(3):446-453. PubMed ID: 37989698
[TBL] [Abstract][Full Text] [Related]
3. Triggering receptor expressed in myeloid cells 1 (TREM1) as a potential prognostic biomarker and association with immune infiltration in oral squamous cell carcinoma.
Kannan B; Pandi C; Pandi A; Jayaseelan VP; Arumugam P
Arch Oral Biol; 2024 May; 161():105926. PubMed ID: 38442472
[TBL] [Abstract][Full Text] [Related]
4. RFC3 serves as a novel prognostic biomarker and target for head and neck squamous cell carcinoma.
Avs KR; Pandi C; Kannan B; Pandi A; Jayaseelan VP; Arumugam P
Clin Oral Investig; 2023 Nov; 27(11):6961-6969. PubMed ID: 37861747
[TBL] [Abstract][Full Text] [Related]
5. Alteration of SERPINH1 is associated with elevated expression in head and neck squamous cell carcinomas and its clinicopathological significance.
Murugesan D; Kannan B; As SG; Jayaseelan VP; Arumugam P
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101811. PubMed ID: 38432483
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma.
Yang J; Song T
Asian Pac J Cancer Prev; 2024 Mar; 25(3):909-919. PubMed ID: 38546073
[TBL] [Abstract][Full Text] [Related]
7. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Expression of BCAS3 in Head and Neck Squamous Cell Carcinoma and Its Association With Prognosis.
Challa D; Pandi C; Kannan B; Priyadharsini VJ; Arumugam P
Cureus; 2023 Dec; 15(12):e50995. PubMed ID: 38259392
[TBL] [Abstract][Full Text] [Related]
9. DYNC1I1 acts as a promising prognostic biomarker and is correlated with immune infiltration in head and neck squamous cell carcinoma.
Ananya RG; Pandi C; Kannan B; Pandi A; Prasad P; Jayaseelan VP; Arumugam P
J Stomatol Oral Maxillofac Surg; 2023 Dec; 125(4):101734. PubMed ID: 38072235
[TBL] [Abstract][Full Text] [Related]
10. Increased SEC14L2 expression is associated with clinicopathological features and worse prognosis in oral squamous cell carcinoma.
David JJ; Kannan B; Pandi C; Jayaseelan VP; Vasagam JM; Arumugam P
Odontology; 2024 Apr; ():. PubMed ID: 38575815
[TBL] [Abstract][Full Text] [Related]
11.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
12. Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma.
Sankar D; Kannan B; Jayaseelan VP; Manicka Vasagam J; Arumugam P
J Oral Biol Craniofac Res; 2024; 14(1):1-7. PubMed ID: 38075236
[TBL] [Abstract][Full Text] [Related]
13. CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma.
Yang Y; Yan C; Chen XJ
BMC Oral Health; 2023 Oct; 23(1):724. PubMed ID: 37803318
[TBL] [Abstract][Full Text] [Related]
14. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of XRCC1 is Associated with Poor Survival in Patients with Head and Neck Squamous Carcinoma and Has Potential to Be Used as Targeted Therapy by Synthetic Lethality.
Ahirwar SS; Lasunte S; Gupta M; Chowdhary R; Kotnis A
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3525-3535. PubMed ID: 37898859
[TBL] [Abstract][Full Text] [Related]
17. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological significance of MRC2 expression in head and neck squamous cell carcinoma.
Gopalakrishnan KV; Kannan B; Pandi C; Jayaseelan VP; Arumugam P
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101617. PubMed ID: 37666484
[TBL] [Abstract][Full Text] [Related]
19. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
[No Abstract] [Full Text] [Related]
20. Aberrant expression of VASP serves as a potential prognostic biomarker and therapeutic target for oral squamous cell carcinoma.
Gopalakrishnan K; Kannan B; Pandi C; Pandi A; Ramasubramanian A; Jayaseelan VP; Arumugam P
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 May; ():. PubMed ID: 38816308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
